Medical Innovation Acceleration Act of 2022
Summary
Medical Innovation Acceleration Act of 2022 This bill exempts noninvasive diagnostic devices from the regulatory authority of the Food and Drug Administration. The bill defines noninvasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2022
Committee Review
Floor Vote
President
Introduced Jan 28, 2022
Last action Jan 31, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
Jan 31, 2022
Committee
Referred to the Subcommittee on Health.
lower
Jan 28, 2022
Committee
Referred to the House Committee on Energy and Commerce.
lower
Jan 28, 2022
Introduced
Introduced in House
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Andy Biggs
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 6513
Scope: US
Hi! I can help you understand HR 6513. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline